Target intelligence / Profile preview

Liver damage

Molecular classification
Other (Liver damage is a pathological process, not a defined molecular entity)
01

Overview

Liver damage refers to the pathological process whereby hepatocytes and other liver cell types undergo injury and death due to a variety of mechanisms, including oxidative stress, immune-mediated damage, toxic metabolite accumulation, and cellular apoptosis or necrosis[6][5][4]. This process underlies many clinical liver diseases, including acute and chronic hepatitis, fatty liver disease, fibrosis, cirrhosis, and hepatocellular carcinoma[1][2][3]. Liver damage is assessed via biochemical markers (such as aminotransferase levels), histology, and increasingly, molecular and genetic markers to determine severity and guide therapy[2][5][7]. It is not itself a receptor, enzyme, or other discrete molecular target but is the endpoint of many converging pathophysiological pathways.

Other names
Liver injuryHepatic injuryHepatocellular damage
02

Mechanism of action

Drugs may reduce liver damage by anti-inflammatory, anti-oxidant, anti-fibrotic, or cytoprotective effects

03

Biological functions

Cell deathInflammationImmune responseTissue repairFibrosis
04

Disease associations

Cancer (e.g., hepatocellular carcinoma secondary to chronic liver damage)Inflammation (central to the process of liver injury and fibrosis)Infection (viral hepatitis, drug-induced liver injury)Other (metabolic, alcoholic, autoimmune disease)
05

Safety considerations

Risk of worsening underlying pathology (e.g., using hepatotoxic drugs in patients with chronic liver disease)Potential for acute liver failure (especially with drug-induced liver injury)
06

Interacting drugs

Acetaminophen

3 more in the full profile.

07

Biomarkers

Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Alkaline phosphatase (ALP)BilirubinCollagen type I alpha 1 chain (COL1A1, marker of fibrosis)Thrombospondin 2 (TSP2, marker of advanced fibrosis)

Beyond the preview

Go deeper on Liver damage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver damage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call